Thursday, November 21, 2013
Print Current Session:
|
|
Thursday
SESSION 57:
MANAGEMENT OF INFECTED GRAFTS AFTER EVAR AND OPEN SURGERY: ROLE OF EVAR FOR MYCOTIC ANEURYSMS
Moderators:Timur P. Sarac, MD / Peter R. Taylor, MA, MChir, FRCS, ARCM
|
|
SESSION 57 SCHEDULE | |
1:00 PM - 1:05 AM | Graft Infections After EVAR: How Should They Be Diagnosed And Treated |
Presenter(s):Keith D. Calligaro, MD | |
View Abstract | |
1:06 PM - 1:11 PM | Treatment Of Infected Grafts After EVAR: Is There Hope |
Presenter(s):Edward Y. Woo, MD | |
1:12 PM - 1:17 PM | Infection Following EVAR: An Under-Reported Problem With Old Solutions And New Challenges: What Should We Be Doing For This Problem |
Presenter(s):Laura Capoccia, MD, PhD | |
1:18 PM - 1:23 PM | Does Semiconservative Treatment Of Infected Aortic Grafts And Endografts – With Salvage Of The Graft Work: What Are The Requirements To Make It Work |
Presenter(s):Martin Malina, MD, PhD | |
1:24 PM - 1:29 PM | Diagnosis Of Vascular Prosthetic Graft Infection By PET/SPECT Scanning |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
1:30 PM - 1:35 PM | How Well Do Cryopreserved Allografts Used In In-Line Reconstructions Work For Aortic Graft Infection: When Should They Not Be Used |
Presenter(s):Peter F. Lawrence, MD | |
1:36 PM - 1:41 PM | In Situ Reconstruction Is The Preferred Treatment For Aortic Graft Enteric Erosion Or Fistula |
Presenter(s):Thomas C. Bower, MD | |
View Abstract | |
1:42 PM - 1:47 PM | Endovascular Treatment Of Infected AAAs (Mycotic Aneurysms): Virulence Of The Organism Is Key: Is Surgical Drainage And Debridement Always Necessary |
Presenter(s):Kamphol Laohapensang, MD | |
View Abstract | |
1:48 PM - 1:53 PM | EVAR Treatment Of Infected AAAs Can Be Effective Long-Term Without Secondary Treatment: What Are The Requirements |
Presenter(s):Boonprasit Kritpracha, MD | |
1:54 PM - 1:59 PM | Next Generation Antimicrobial Silver-Triclosan Vascular Prosthetic Grafts (Synergy/Maquet): How Good Will They Be And Will They Enable In Situ Repair In Patients With Graft Infections (European Results) |
Presenter(s):Max Zegelman, MD, PhD | |
View Abstract | |
2:00 PM - 2:06 PM | Panel Discussion |
END OF SESSION 57 | |
previous | next |